COMP <GO>
ALTO vs LIN // ALTMAN Z-SCORE & DEBT/EQUITY
Alto Ingredients Inc. (NASDAQ) VS. Linde plc (NASDAQ) • 15-METRIC TALLY: ALTO 1
— LIN 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: LIN
LAST: $3.65 (-0.27%) • MKT CAP: $283.1M
balance-sheet
0.98
LAST: $503.15 (-0.99%) • MKT CAP: $231.94B
balance-sheet
3.93
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALTO VS. LIN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALTO | LIN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 3.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.00% | 13.10% | -11.10 | LIN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 28.6x | 18.5x | +10.10 | LIN | /valuation <GO> |
| Free Cash Flow Yield | 3.05% | 2.19% | +0.86 | ALTO | /fcf-yield <GO> |
| Operating Margin | 0.80% | 26.30% | -25.50 | LIN | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 20.30% | -20.30 | LIN | /net-margins <GO> |
| Revenue Growth (YoY) | -4.90% | 3.00% | -7.90 | LIN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.21% | -1.21 | LIN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 0.98 | 3.93 | -2.95 | LIN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 56.6 | -10.94 | LIN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.01 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 31.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $283.1M | $231.94B | -$231.66B | LIN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALTO REV | LIN REV | ALTO GROSS % | LIN GROSS % | ALTO FCF | LIN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $917.9M | $33.99B | 3.8% | — | $8.6M | $5.09B |
| FY 2024 | $965.3M | $33.01B | 1.0% | — | -$14.6M | $4.93B |
| FY 2023 | $1.22B | $32.85B | — | — | $22.0M | $7.83B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALTO // BETA —
LIN // BETA 1.01